Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Craig Miller

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Clinical Chemistry|February 10, 2007
MESOMARK: a potential test for malignant pleural mesotheliomaHeather L Beyer, Ryan D Geschwindt, Curtis L Glover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancerJohann S de Bono, Howard I Scher, R Bruce Montgomery, et al.
Cancer|February 6, 2003
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation studyAlexander Haese, Manisha Chaudhari, M Craig Miller, et al.
British Journal of Cancer|January 16, 2020
Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survivalAfroditi Nanou, M Craig Miller, Leonie L Zeune, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 26, 2015
A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive PhenotypeGuangjing Zhu, Zhi Liu, Jonathan I Epstein, et al.
Scientific Reports|January 7, 2014
HE4 (WFDC2) gene overexpression promotes ovarian tumor growthRichard G Moore, Emily K Hill, Timothy Horan, et al.
The New England Journal of Medicine|August 20, 2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancerMassimo Cristofanilli, G Thomas Budd, Matthew J Ellis, et al.
Molecular Oncology|March 30, 2013
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancerJeffrey B Smerage, G Thomas Budd, Gerald V Doyle, et al.
Clinical Colorectal Cancer|June 4, 2016
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical PracticeMartin Wilhelm, Lothar Mueller, M Craig Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancerMassimo Cristofanilli, Daniel F Hayes, G Thomas Budd, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Clinical Chemistry|February 10, 2007
MESOMARK: a potential test for malignant pleural mesotheliomaHeather L Beyer, Ryan D Geschwindt, Curtis L Glover, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancerJohann S de Bono, Howard I Scher, R Bruce Montgomery, et al.
Cancer|February 6, 2003
Quantitative biopsy pathology for the prediction of pathologically organ-confined prostate carcinoma: a multiinstitutional validation studyAlexander Haese, Manisha Chaudhari, M Craig Miller, et al.
British Journal of Cancer|January 16, 2020
Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survivalAfroditi Nanou, M Craig Miller, Leonie L Zeune, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 26, 2015
A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive PhenotypeGuangjing Zhu, Zhi Liu, Jonathan I Epstein, et al.
Scientific Reports|January 7, 2014
HE4 (WFDC2) gene overexpression promotes ovarian tumor growthRichard G Moore, Emily K Hill, Timothy Horan, et al.
The New England Journal of Medicine|August 20, 2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancerMassimo Cristofanilli, G Thomas Budd, Matthew J Ellis, et al.
Molecular Oncology|March 30, 2013
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancerJeffrey B Smerage, G Thomas Budd, Gerald V Doyle, et al.
Clinical Colorectal Cancer|June 4, 2016
Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical PracticeMartin Wilhelm, Lothar Mueller, M Craig Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2005
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancerMassimo Cristofanilli, Daniel F Hayes, G Thomas Budd, et al.
Pageof 6